Stay updated with breaking news from Jonathon Sedgwick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Collaboration to leverage AbbVie's therapeutic area expertise and Tentarix's Tentacles™ platform, to develop novel multifunctional biologics against one target in oncology and another in...
/PRNewswire/ -- The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, announced today that AbbVie...
AbbVie to maintain exclusive access to Calibr-Skaggs' switchable CAR-T platform to develop novel cell therapy candidates against solid tumor targets identified by AbbVieAbbVie also has the option...
AbbVie Inc. (NYSE: ABBV) and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies in oncology and neuroscience. Working closely with AbbVie, BigHat will utilize its Milliner™ platform, a ...
AbbVie Inc. (NYSE: ABBV) and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies in oncology and neuroscience. Working closely with AbbVie, BigHat will utilize its Milliner™ platform, a ...